Asian Pacific journal of cancer prevention : APJCP · 2026
Salivary Malondialdehyde as a Marker of Oxidative Stress in Tobacco Chewers, with and without Oral Submucous Fibrosis: A Comparative, Cross-Sectional Biochemical Study.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Waikhom Sylvia, Rathore Akshay, Yadav Anuradha, Tikoo Parul, Uma Devi Achom, Saba Qazi
Аннотация
OBJECTIVE: This study aimed to evaluate and compare salivary Malondialdehyde (MDA) levels in tobacco chewers with and without oral submucous fibrosis, and healthy individuals, and correlate the levels with stages of oral submucous fibrosis.
METHODS: This cross-sectional study was conducted in ITS-Centre for Dental Studies and Research, Ghaziabad, India which included 60 subjects divided into three groups: Group A: Healthy controls (n=20) Group B: Tobacco chewers with clinically and histopathologically confirmed Oral Submucous Fibrosis (OSMF) (n=20) Group C: Tobacco chewers without OSMF (n=20). Unstimulated whole saliva was collected, centrifuged, and stored at -20°C. Salivary MDA levels were estimated by enzyme-linked immunosorbent assay (ELISA) using thiobarbituric acid reactive substances (TBARS).
RESULTS: Salivary MDA levels were significantly higher in oral submucous fibrosis patients (mean ± SD: 49.57 ± 25.91 mmol/L) compared to tobacco chewers without oral submucous fibrosis (21.21 ± 7.76 mmol/L) and healthy individuals (10.96 ± 2.90 mmol/L),with p < 0.001. A statistically significant positive correlation was found between MDA levels and stages of oral submucous fibrosis, indicating increased oxidative stress with disease progression.
CONCLUSION: Elevated salivary MDA levels in oral submucous fibrosis patients reflect increased oxidative stress and its correlation with disease severity.
METHODS: This cross-sectional study was conducted in ITS-Centre for Dental Studies and Research, Ghaziabad, India which included 60 subjects divided into three groups: Group A: Healthy controls (n=20) Group B: Tobacco chewers with clinically and histopathologically confirmed Oral Submucous Fibrosis (OSMF) (n=20) Group C: Tobacco chewers without OSMF (n=20). Unstimulated whole saliva was collected, centrifuged, and stored at -20°C. Salivary MDA levels were estimated by enzyme-linked immunosorbent assay (ELISA) using thiobarbituric acid reactive substances (TBARS).
RESULTS: Salivary MDA levels were significantly higher in oral submucous fibrosis patients (mean ± SD: 49.57 ± 25.91 mmol/L) compared to tobacco chewers without oral submucous fibrosis (21.21 ± 7.76 mmol/L) and healthy individuals (10.96 ± 2.90 mmol/L),with p < 0.001. A statistically significant positive correlation was found between MDA levels and stages of oral submucous fibrosis, indicating increased oxidative stress with disease progression.
CONCLUSION: Elevated salivary MDA levels in oral submucous fibrosis patients reflect increased oxidative stress and its correlation with disease severity.